Lung Cancer

Our lung cancer research team is dedicated to integrating basic research with clinical practice, and through international research collaborations, we delve into the pathogenesis, heterogeneity, and ethnic differences of lung cancer. We actively participate in international research projects, combining clinical data and research resources from multiple countries to enhance the international impact and clinical applicability of our research findings. Our core research focuses on early screening and risk assessment of lung cancer, combining low-dose computed tomography (LDCT), molecular biomarkers, and artificial intelligence analysis techniques to develop more precise screening and prediction models, thereby improving early detection rates and reducing the proportion of late-stage diagnoses. Through deep integration of interdisciplinary and international research, we gain a more comprehensive understanding of the disease progression and early lesion characteristics of lung cancer, accelerating the development of screening strategies and clinical decision-making tools. Each research finding reflects the team's long-term commitment to translational research, international collaboration, and precision medicine, striving to transform research evidence into practically applicable clinical and public health strategies.